European Commission expected to rubber-stamp regulator’s recommendations within days
Sarah Boseley, health editor
Mass vaccination against swine flu could begin within weeks, following the approval of two vaccines by the European regulator today.
One of the two recommended for a licence by the European Medicines Agency (EMEA) is Pandemrix, the vaccine made by British company GlaxoSmithKline (GSK) which is under contract to supply the UK. The other is Focetria, made by the Swiss company Novartis.
The UK has also signed a contract with Baxter, but the EMEA said yesterday that it needed some information about its vaccine, called Celvapan. The agency hopes to be able to approve it next week. Read More…
